Blood glucose control in a patient with diabetes mellitus after facial composite allotransplantation
10.3760/cma.j.issn.1671-7368.2011.05.019
- VernacularTitle:异体颜面复合组织移植患者术后糖尿病个体化降糖治疗一例
- Author:
Jingbo LAI
;
Li WANG
;
Jianfang FU
;
Nanyan ZHANG
;
Deqiang LI
;
Shuzhong GUO
;
Hongwei CAO
;
Xiangyang LIU
;
Qiuhe JI
- Publication Type:Journal Article
- Keywords:
Diabetes mellitus;
Therapy
- From:
Chinese Journal of General Practitioners
2011;10(5):341-343
- CountryChina
- Language:Chinese
-
Abstract:
A facial allotransplanted patient presented hyperglycemia with blood glucose ranged 14. 3 -33. 3 mmol/L after receiving immunosuppressive drugs and glucocorticoids. To control the blood glucose level, the patient was treated with two subcutaneous doses of 10 U human neutral protamine hagedorn (NPH) insulin, and the fasting glucose level came down to 3. 6 - 9. 4 mmol/L. Then the continuous subcutaneous infusion of insulin aspart ( Novo Industri) was administrated (from 96 to 21 U/d) , and the fasting blood glucose levels were 3. 9 -4. 6 mmol/L. With oral administration of Metformin and Repaglinide, the fasting blood glucose was maintained to 4. 3 -5.9 mmol/L. With these medications, the blood glucose level of the patient was under good control and the acute and chronic complications of hyperglycemia were effectively prevented.